This figure corresponds to the Average Price over the previous 50/200 days.
For bluebird bio stocks, the 50-day moving average is the support level today.
For bluebird bio stocks, the 200-day moving average is the support level today.
Are you interested in bluebird bio, Inc. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the bluebird bio
stock price in 2024, 2025, 2026, 2027, 2028.
How much will one bluebird bio share be worth in
2024 - 2028?
When should I take profit in bluebird bio stock?
When should I record a loss on bluebird bio stock?
What are analysts' forecasts for bluebird bio stock?
What is the future of bluebird bio stock?
We forecast bluebird bio stock performance using neural networks based on historical data on bluebird bio stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
bluebird bio stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2024, 2025, 2026, 2027 and 2028)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for bluebird bio shares. This happens once a day.
Historical and forecast chart of bluebird bio stock
The chart below shows the historical price of bluebird bio stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the bluebird bio stock price can be found in the table below.
Long-term forecasts by years.
Bluebird Bio, Inc. provides biotech products and services: gene therapy for serious genetic disorders such as infantile cerebral adrenoleukodystrophy, neurodegenerative disorders and beta thalassemia. The company operates in the United States.
Forecast target price for 12-07-2023: $6.25. Positive dynamics for bluebird bio shares will prevail with possible volatility of 5.298%. Pessimistic target level: 6.08 Optimistic target level: 6.42
bluebird bio Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $6.19. Negative dynamics for bluebird bio shares will prevail with possible volatility of 3.843%. Pessimistic target level: 6.01 Optimistic target level: 6.25
bluebird bio Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $6.14. Negative dynamics for bluebird bio shares will prevail with possible volatility of 2.755%. Pessimistic target level: 6.07 Optimistic target level: 6.24
bluebird bio Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $5.93. Negative dynamics for bluebird bio shares will prevail with possible volatility of 4.152%. Pessimistic target level: 5.81 Optimistic target level: 6.06
bluebird bio Stock Forecast 12-11-2023.
Forecast target price for 12-11-2023: $6.12. Positive dynamics for bluebird bio shares will prevail with possible volatility of 3.148%. Pessimistic target level: 6.02 Optimistic target level: 6.22
bluebird bio Stock Forecast 12-12-2023.
Forecast target price for 12-12-2023: $6.07. Negative dynamics for bluebird bio shares will prevail with possible volatility of 3.379%. Pessimistic target level: 5.97 Optimistic target level: 6.18
Market capitalization of the bluebird bio, Inc. is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of BLUE shares in the company outstanding by the market price of one share.
EBITDA:
-131 774 000 $
EBITDA of bluebird bio is earnings before interest, income tax and depreciation of assets.
PE Ratio:
None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
0.32
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
-0.63
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
N/A
Quarterly Revenue Growth YOY:
173.53
Trailing PE:
-
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
-
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
25.38
Enterprise Value (EV) /Revenue
EV To EBITDA:
-4.185
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
109336000
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website